SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England: the School Infection Survey, a national open cohort study, November 2021SARS-CoV-2 antibody prevalence in school children.

Powell, AA; Ireland, G; Leeson, R; Lacey, A; Ford, B; Poh, J; Ijaz, S; Shute, J; Cherepanov, P; Tedder, R; et al. Powell, AA; Ireland, G; Leeson, R; Lacey, A; Ford, B; Poh, J; Ijaz, S; Shute, J; Cherepanov, P; Tedder, R; Bottomley, C; Dawe, F; Mangtani, P; Jones, P; Nguipdop-Djomo, P; Ladhani, SN; COVID-19 Schools Infection Survey Group (2023) National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England: the School Infection Survey, a national open cohort study, November 2021SARS-CoV-2 antibody prevalence in school children. J Infect, 86 (4). pp. 361-368. ISSN 1532-2742 https://doi.org/10.1016/j.jinf.2023.02.016
SGUL Authors: Ladhani, Shamez Nizarali

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (969kB) | Preview
[img] Microsoft Word (.docx) (Supplementary material) Published Version
Available under License Creative Commons Attribution.

Download (161kB)

Abstract

BACKGROUND: SARS-CoV-2 infection rates are likely to be underestimated in children because of asymptomatic or mild infections. We aim to estimate national and regional prevalence of SARS-CoV-2 antibodies in primary (4-11 years old) and secondary (11-18 years old) school children between 10 November and 10 December 2021. METHODS: Cross-sectional surveillance in England using two-stage sampling, firstly stratifying into regions and selecting local authorities, then selecting schools according to a stratified sample within selected local authorities. Participants were sampled using a novel oral fluid-validated assay for SARS-CoV-2 spike and nucleocapsid IgG antibodies. RESULTS: 4980 students from 117 state-funded schools (2706 from 83 primary schools, 2274 from 34 secondary schools) provided a valid sample. After weighting for age, sex, and ethnicity, and adjusting for assay accuracy, the national prevalence of SARS-CoV-2 antibodies in primary school students, who were all unvaccinated, was 40.1% (95% CI 37.3-43.0). Antibody prevalence increased with age (p < 0.001) and was higher in urban than rural schools (p = 0.01). In secondary school students, the adjusted, weighted national prevalence of SARS-CoV-2 antibodies was 82.4% (95% CI 79.5-85.1); including 71.5% (95% CI 65.7-76.8) in unvaccinated and 97.5% (95% CI 96.1-98.5) in vaccinated students. Antibody prevalence increased with age (p < 0.001), and was not significantly different in urban versus rural students (p = 0.1). CONCLUSIONS: In November 2021, using a validated oral fluid assay, national SARS-CoV-2 seroprevalence was estimated to be 40.1% in primary school students and 82.4% in secondary school students. In unvaccinated children, this was approximately threefold higher than confirmed infections highlighting the importance of seroprevalence studies to estimate prior exposure. DATA AVAILABILITY: Deidentified study data are available for access by accredited researchers in the ONS Secure Research Service (SRS) for accredited research purposes under part 5, chapter 5 of the Digital Economy Act 2017. For further information about accreditation, contact Research.support@ons.gov.uk or visit the SRS website.

Item Type: Article
Additional Information: Crown Copyright © 2023 Published by Elsevier Ltd on behalf of The British Infection Association. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Keywords: Antibodies, COVID-19 vaccination, Oral fluid, SARS-CoV-2, School pupils, Seroprevalence, Child, Humans, Child, Preschool, Adolescent, SARS-CoV-2, Cohort Studies, Cross-Sectional Studies, Prevalence, Seroepidemiologic Studies, COVID-19, Antibodies, Viral, England, Schools, COVID-19 Schools Infection Survey Group, Humans, Antibodies, Viral, Prevalence, Cohort Studies, Cross-Sectional Studies, Seroepidemiologic Studies, Schools, Adolescent, Child, Child, Preschool, England, COVID-19, SARS-CoV-2, Seroprevalence, SARS-CoV-2, Antibodies, Oral fluid, School pupils, COVID-19 vaccination, 1103 Clinical Sciences, Microbiology
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: J Infect
ISSN: 1532-2742
Language: eng
Dates:
DateEvent
1 April 2023Published
15 February 2023Published Online
10 February 2023Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
FC001061Cancer Research UKhttp://dx.doi.org/10.13039/501100000289
UNSPECIFIEDDepartment of Health and Social Carehttp://dx.doi.org/10.13039/501100000276
FC001061Wellcome Trusthttp://dx.doi.org/10.13039/100004440
FC001061Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
PubMed ID: 36803676
Web of Science ID: WOS:000997552100001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/115540
Publisher's version: https://doi.org/10.1016/j.jinf.2023.02.016

Actions (login required)

Edit Item Edit Item